Literature DB >> 11581407

Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.

Q Zhong1, P Oliver, W Huang, D Good, V La Russa, Z Zhang, J R Cork, R W Veith, C Theodossiou, J K Kolls, P Schwarzenberger.   

Abstract

We have previously reported effective gene transfer with a targeted molecular conjugate adenovirus vector through the c-kit receptor in hematopoietic progenitor cell lines. However, a c-kit-targeted recombinant retroviral vector failed to transduce cells, indicating the existence of significant differences for c-kit target gene transfer between these two viruses. Here we demonstrate that conjugation of an adenovirus to a c-kit-retargeted retrovirus vector enables retroviral transduction. This finding suggests the requirement of endosomalysis for successful c-kit-targeted gene transfer. Furthermore, we show efficient gene transfer to, and high transgene expression (66%) in, CD34-selected, c-kit(+) human peripheral blood stem cells using a c-kit-targeted adenovirus vector. These findings may have important implications for future vector development in c-kit-targeted stem cell gene transfer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581407      PMCID: PMC114613          DOI: 10.1128/JVI.75.21.10393-10400.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  Chimeric viral vectors--the best of both worlds?

Authors:  P N Reynolds; M Feng; D T Curiel
Journal:  Mol Med Today       Date:  1999-01

2.  Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells.

Authors:  P L Leopold; B Ferris; I Grinberg; S Worgall; N R Hackett; R G Crystal
Journal:  Hum Gene Ther       Date:  1998-02-10       Impact factor: 5.695

3.  Receptor-targeted recombinant adenovirus conglomerates: a novel molecular conjugate vector with improved expression characteristics.

Authors:  P Schwarzenberger; J D Hunt; E Robert; C Theodossiou; J K Kolls
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Retroviral vector targeting human cells via c-Kit-stem cell factor interaction.

Authors:  T Yajima; T Kanda; K Yoshiike; Y Kitamura
Journal:  Hum Gene Ther       Date:  1998-04-10       Impact factor: 5.695

5.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

6.  Gene therapy -- promises, problems and prospects.

Authors:  I M Verma; N Somia
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

7.  Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy.

Authors:  J A Moscow; H Huang; C Carter; K Hines; J Zujewski; G Cusack; C Chow; D Venzon; B Sorrentino; Y Chiang; B Goldspiel; S Leitman; E J Read; A Abati; M M Gottesman; I Pastan; S Sellers; C Dunbar; K H Cowan
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

8.  Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens.

Authors:  J S Smith; J R Keller; N C Lohrey; C S McCauslin; M Ortiz; K Cowan; S E Spence
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

9.  Poly-L-lysine-based molecular conjugate vectors: a high efficiency gene transfer system for human progenitor and leukemia cells.

Authors:  P Schwarzenberger; W Huang; P Oliver; T Osidipe; C Theodossiou; J K Kolls
Journal:  Am J Med Sci       Date:  2001-02       Impact factor: 2.378

10.  High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors.

Authors:  B M Frey; N R Hackett; J M Bergelson; R Finberg; R G Crystal; M A Moore; S Rafii
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

View more
  3 in total

1.  Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization.

Authors:  Joseph S Anderson; Jon Walker; Jan A Nolta; Gerhard Bauer
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

2.  Parvovirus infection suppresses long-term repopulating hematopoietic stem cells.

Authors:  José C Segovia; Guillermo Guenechea; Jesús M Gallego; José M Almendral; Juan A Bueren
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule.

Authors:  Steven Froelich; Leslie Ziegler; Katie Stroup; Pin Wang
Journal:  Biotechnol Bioeng       Date:  2009-09-01       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.